| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … Type: | 0 | 0 | 0 | 20 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 7 | 5 | 1 | 47 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid Type: | 0 | 0 | 0 | 25 |
 | Eurofins BIO-EC [Automatic translation follows] French laboratory specializing in studies of the effectiveness of cosmetic and dermatological products for 24 years 🔬 Since 1998, the BIO-EC Laboratory has specialized in evaluating the effectiveness of cosmetic and dermatological products (finished or active products), but also medical devices and food supplements. Our activity is organized around several areas: 🔸 Ex vivo studies on human skin explants maintained in survival 🔸 In vivo studies on a panel of healthy volunteers 🔸 Skin absorption studies 🔸 RAMAN spectroscopy studies 🔸 Cosmetogenomic studies All of the studies we carry out are customizable in order to best meet … Type: | 1 | 0 | 1 | 32 |
 | Mibelle Biochemistry Inspired by nature - realized by science 🍏 Inspired by nature – Realized by science Designing ideas for added value In the fast-moving cosmetic industry, innovation is the most important factor as it enables us to deliver new claims, new efficacy tests, new applications, new biochemical findings, as well as new marketing and communication tools to effectively differentiate products. At Mibelle Biochemistry, our mission is to design the most innovative actives for our customers. Inspired by nature – realized by science Our scientists transform naturally derived plant compounds into truly functional bioactive cosmetic ingredients. Our R&D team makes use of … Type: | 0 | 0 | 0 | 82 |
 | Zeta Farmaceutici Group [Automatic translation follows] Pharmaceuticals and cosmetics: two great Italian traditions. We renew them every day. Zeta Farmaceutici Group is an Italian industrial reality made up of a group of companies specialized in the development, production and distribution of drugs, medical devices, cosmetics, food supplements, biocides. 1. Production and marketing of products with own brands. Our brands are present in 10,000 pharmacies and parapharmacies, with widespread distribution throughout Italy. 2. Contract manufacturing. Industrial partnership with national and international companies and groups. Our brands. Euphidra. Make up, dermoscomesis, hair coloring, personal hygiene. Amido Mio. The rice starch line to cleanse and protect … Type: | 0 | 0 | 0 | 133 |
 | PAVmed Inc. Nasdaq: PAVM PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. cardiology, orthopedics, gastroenterology, and healthcare economics Type: | 1 | 0 | 1 | 45 |
 | MOLECUBES NV Making molecular imaging available to anyone. At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute … Type: | 3 | 1 | 1 | 26 |
 | BIOSENIC S.A. New solutions for autoimmune, inflammatory and bone diseases. BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair. Cell therapy, Bone and joint tissue regeneration, Osteo-Articular Diseases, autoimmunity, immunity, autoimmune disease, and arsenic Type: | 6 | 3 | 2 | 27 |
 | QUANTA MEDICAL [Automatic translation follows] 33 years of clinical research in Pharma, Medical Device & Dermo-Cosmetics QUANTA MEDICAL Shared experience CRO since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, food, dermatology, cosmetics and medical device industries, 30 years of expertise in Human Health reinforced by: - double ISO 9001 & 27001 - dedicated technical tools (QUANTA VIEW®, E-CRF, Trial-On-Line®) Clinical Research / Clinical Trial, e-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT Development, Health Risk Assessment, and Regulatory … Type: | 0 | 0 | 0 | 9 |
 | Atomo Diagnostics Empowering Healthcare Consumers Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) … Type: | 0 | 0 | 0 | 27 |
 | Registrar Corp Registrar Corp assists companies with U.S. FDA Regulations Registrar Corp provides U.S. FDA registration, U.S. agent, and regulatory compliance assistance for U.S. and non-U.S. companies in the food and beverage, medical device, drug, cosmetics, and radiation-emitting device industries. Registrar Corp provides expert assistance in 19 different languages, 24 hours per day, 7 days per week. Registrar Corp was founded in 2003 to assist businesses with compliance with U.S. Food and Drug Administration (U.S. FDA) regulations. Since opening its headquarters in Hampton, Virginia, USA, Registrar Corp has expanded to nineteen international offices and has aided more than 20,000 companies across 150 … Type: | 1 | 0 | 1 | 263 |
 | Zilico Limited Real-time medical diagnostics Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs. ZedScanTM, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal cervical screening result, increasing diagnostic accuracy and delivering health economic benefits. Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable … Type: | 5 | 1 | 4 | 7 |
 | NIOX® NIOX Group plc is a dedicated diagnostics and monitoring company focused on respiratory disease. NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary … Type: | 3 | 1 | 0 | 125 |
 | Francelab [Automatic translation follows] At FranceLab we are dedicated to manufacturing medicines with the highest quality standards. Francelab is a national pharmaceutical company dedicated exclusively to oral hypoglycemic medications. Located in the Tigre industrial park. Our Vision: To become a company with a national presence that achieves commercial results based on quality, friendship and communication with doctors, patients, social works and distribution channel. Our Mission: Produce medicines and relationships that exceed the quality standard Our commitment: Is to promote and maintain a culture of respect. We do not discriminate based on gender, religion, ethnicity, nationality, culture, social group, disability, illness, sexual … Type: | 0 | 0 | 0 | 29 |
 | AURAL Alsace [Automatic translation follows] Progress 🚩and innovate🚀 Cooperate and commit to humanity HISTORICAL Created in 1972 by Professor JAHN, Head of the Nephrology and Hemodialysis Department at the Strasbourg University Hospital, AURAL is a non-profit association offering all treatment modalities for chronic kidney failure as well as hospitalization activity. at home and is present throughout the Alsace region. HAD's activity started in May 2004. In 1981 AURAL started Continuous Ambulatory Peritoneal Dialysis. The first assisted AD units were set up in 1985, and in 1996 they were the UMs. The DPA was created in 1994, and allows young patients to continue … Type: | 2 | 2 | 0 | 131 |
 | GMED [Automatic translation follows] GMED is a certification body and a French notified body in Europe (identification number 0459). GMED is a certification body and a French notified body in Europe (identification number 0459). It is responsible for assessing the conformity of medical devices according to the applicable European directives (90/385/CEE, 93/42/CEE and 98/79/EC). Accredited by the French Accreditation Committee COFRAC (under certificate No. 4-0608), in accordance with standard NF EN ISO/CEI 17021: 2015, GMED carries out quality management system certification activities according to ISO standards 9001:2015 and ISO 13485:2016. GMED is also an auditing organization recognized by the MDSAP Regulatory … Type: | 4 | 2 | 2 | 75 |
 | HC NEXT Expert en gestion de projet de développement de produits de santé innovants HC NEXT is a consulting company expert in project management and vendor management for drug and medical device development! HC NEXT’s mission is to speed up and derisk drugs and medical devices developments to ensure that each innovation becomes a product to patient’s benefit. HC NEXT consultants are both project management specialists and generalists in the field of healthcare product development. We kindly but seriously challenge habits, routine, bias, status quo, prejudices. Dare to be different! Type: | 3 | 1 | 3 | 3 |
 | MBCP® Technology (Advanced Medical Solutions) experts in bone regeneration Biomatlante is a specialist in synthetic biomaterials promoting bone regrowth and the precursor of bone substitute technologies. We market our products for orthopedic, trauma, spine, ENT, stomatological and dental surgery in more than 50 countries. Our Mission Develop and promote the proprietary MBCP® Technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. Our Vision Bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. Autograft is available in limited quantity though, and harvesting methods are expensive … Type: | 1 | 1 | 1 | 28 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 15 | 8 | 9 | 7 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 5 | 2 | 3 | 33 |
 | Global D [Automatic translation follows] Partner of your Surgeries Global D is a French company specializing in the design, manufacturing and provision of quality medical devices intended for maxillofacial, pre-implant, orthodontic and dental implantology surgeries. Global D, partner of your surgeries. a company of the Menix group medical devices, dental implants, and max-fac implants Type: | 4 | 1 | 3 | 156 |
 | INSTITUT FRANCAIS D'HYPNOSE - IFH [Automatic translation follows] Professional training and research center since 1990 The French Institute of Hypnosis is a professional training organization which has offered, since 1990, training in medical and psychotherapeutic hypnosis, within a strict ethical framework, based on the most recent scientific research, and exclusively for health professionals (general practitioners and specialists, dentists, midwives, nurses, etc.), clinical psychologists, psychotherapists. Over the years, several thousand people, practicing privately or in hospitals, have followed our training programs. As a historic player in the medical hypnosis sector, we wish to actively contribute to the development of hypnosis for therapeutic purposes in France. Hypnosis, … Type: | 0 | 0 | 0 | 29 |
 | OncoDNA - IntegraGen Company specializing in the genomics of cancer and genetic diseases IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of … Type: | 3 | 1 | 2 | 57 |
 | Protilab [Automatic translation follows] Creator of smiles for all Created in 2006, Protilab is the only ISO certified dental prosthesis laboratory in its sector. The work is carried out in its ultra-modern dental prosthesis laboratory certified ISO 9001:2008 and ISO 13485:2003. Protilab has, in its Parisian premises, a fully equipped laboratory allowing the execution and repair of all express work. Protilab offers 5 quality commitments: • Certification • Materials • Traceability • Follow up • Guarantee dental prosthesis laboratory, joint prostheses, assistant prostheses, CAD/CAM, digital impression management, and prostheses on implants Type: | 0 | 0 | 0 | 37 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 13 |
 | Dermadry Laboratories inc. Creators of the anti-sweat device. Dermadry is the world's leading manufacturer of iontophoresis machines for the treatment of hyperhidrosis, a medical condition characterized by excessive sweating that affects approximately 1 in 20 people worldwide. We offer three tailored solutions to treat the three areas most commonly affected by hyperhidrosis: the hands, feet, and underarms. Our Canadian-made range of iontophoresis machines include the Dermadry Hands & Feet, Dermadry Underarms, and the all-in-one Dermadry Total. Our FDA cleared and CE marked iontophoresis machines are an effective and non-invasive way to treat excessive sweating from the comfort and privacy of your home. During … Type: | 0 | 0 | 0 | 9 |
 |  Drug and Alcohol Testing Institute (DAT Institute) Promote educational opportunities, advance "best practices," and benchmarking opportunities for DER's. Program Managers, Promoting a drug and alcohol-free workplace by advancing professionalism through quality education and best practices. Education, Networking, Regulatory Compliance, Drug Testing, Alcohol Testing, Safety, and Human Resources Type: | 2 | 0 | 2 | 1 |
 | Cellulis Automation and standardization of cryopreservation processes for Cell Therapies Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns. Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies Type: | 0 | 0 | 0 | 3 |
 | Biosantech [Automatic translation follows] TO DATE, THE MOST ADVANCED THERAPEUTIC AIDS VACCINE IN THE WORLD BIOSANTECH, created in April 2011 by Roger and Corinne TREGER, is an innovative company with an equitable NORTH/SOUTH vocation based in Sophia Antipolis Valbonne in the Provence-Alpes Cote d’Azur region. BIOSANTECH aims to promote and develop a vaccine effective against all variants of the AIDS virus. BIOSANTECH has an exclusive cooperation agreement with the CNRS and the University of Aix Marseille and is the owner of the exclusive license for the valorization and marketing of vaccine patents from “TAT Oyi”. BIOSANTECH, to date, has the only … Type: | 1 | 1 | 0 | 7 |
 | Spiderwort Inc. Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body. Type: | 0 | 0 | 0 | 23 |
 | DTU Health Tech Technology for human health and well-being We develop health technology that makes life better for people. DTU Health Tech educates the engineers of the future, and develop new technology and solutions with a vision to improve people's life before, during and after they are patients. We do this in close collaboration with the health sector, industry, academia and other health partners, because we believe that the best results and ideas often occur in a close collaboration between different sectors. Health technology, Bioinformatics, Biomimetics, Biotherapeutic engineering, Digital health, Drug delivery, Immunology, Hearing research, Magnetic resonance, Medical isotopes, Dosimetry, Optical sensing, Ultrasound, … Type: | 1 | 0 | 1 | 148 |
 | Clarity Make brain health accessible for everyone, everywhere. Clarity leverages light and sound to pioneer a new category of therapeutics for neurological conditions. Type: | 6 | 2 | 5 | 9 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an abitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 13 |
 |  Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: | 0 | 0 | 0 | 15 |
 | Cellply Unravelling immune system function, one cell at a time Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented … Type: | 0 | 0 | 0 | 33 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 19 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 51 |
 | MedTrace Pharma A/S We innovate medical imaging to help health care professionals diagnose patients better and faster. MedTrace is striving to minimize diagnostic uncertainty through better perfusion imaging. Perfusion imaging provides medical professionals with a functional understanding of the organs blood supply inside the patient. MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly. Our solution allows for absolute blood flow quantification based upon the PET tracer 15O-water, which has long been acknowledged as the gold standard tracer for non-invasive blood flow quantification. Our innovative solution is intended to making 15O-water practically available right next to … Type: | 0 | 0 | 0 | 45 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 15 |
 | Pathios Therapeutics Pioneering a novel macrophage conditioning approach to deliver breakthrough cancer therapies Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of tumour-associated macrophages (TAMs). We are currently engaged in a fully-enabled drug discovery program to identify novel small-molecule modulators of GPR65 with expected utility across a broad spectrum of cancers. We are also more broadly interested in the potential to target GPR65 for benefit in a range of other serious … Type: | 2 | 0 | 0 | 18 |
 | Synamics Therapeutics Pioneering Adaptive Medicine: AI-Powered Solutions to Overcome Drug Resistance in Cancer and Infectious Diseases At Synamics Therapeutics, our mission is crystal clear: we harness advanced computational and AI/ML techniques to profoundly impact patients' lives. As an end-to-end drug discovery company, we're dedicated to revolutionizing intractable cancer and infectious diseases through AI-powered adaptive drug design. Our interdisciplinary team uncovers drug resistance mechanisms, identifies unique therapeutic targets, and customizes treatments based on individual molecular profiles. We're driven by a deep commitment to redefine healthcare through next-generation precision medicine and AI-driven drug discovery. Beyond genomics, we employ a versatile approach to dissect proteins … Type: | 3 | 0 | 2 | 7 |
 | TOLREMO therapeutics Stopping non-genetic cancer drug resistance as it emerges TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit. Drug Discovery, Drug Development, Cancer Drug … Type: | 1 | 0 | 1 | 11 |
 | SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors. Type: | 1 | 0 | 1 | 8 |
 | HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies Type: | 1 | 0 | 1 | 19 |
 | OKYO Pharma OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations. Type: | 2 | 0 | 0 | 9 |
 | Mikrobiomik rethinking microbiome Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic … Type: | 1 | 0 | 1 | 20 |
 | Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotechnology company with a mission to develop novel Treg therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to enhance Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: | 5 | 0 | 5 | 10 |
 | ThirtyFiveBio Applying proprietary understanding of GPR35 biology to develop novel small-molecule modulators. ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35 Type: | 1 | 0 | 1 | 15 |
 | BioLamina Cell-specific culture matrices for improved cell functionality BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including the reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types. Our chemically defined and xeno-free laminin cell culture matrices allow you to imitate the natural cell-matrix interaction in vitro. Laminins are key components of the extracellular matrix. Through their interactions with specific receptors, laminins trigger the authentic cellular responses, pivotal for cell anchorage, survival, proliferation, migration, organization, … Type: | 0 | 0 | 0 | 95 |
 | Rejuveron Life Sciences AG Helping people live longer, healthier lives. Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer. Type: | 0 | 0 | 0 | 18 |
 | AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Genes Therapy AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh. AlveoGene has secured an exclusive licence to a proprietary and validated … Type: | 0 | 0 | 0 | 2 |
 | Broken String Biosciences Turning breaks into breakthroughs Broken String Bioscience’s technology platform, INDUCE-seqTM, supports the development of cell and gene therapies that are safer by design. INDUCE-seqTM, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. Type: | 2 | 0 | 1 | 38 |
 | Galactica Biotech Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications Type: | 0 | 0 | 0 | 1 |
 | Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: | 4 | 1 | 2 | 59 |
 | Carisma Therapeutics Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors Carisma Therapeutics is a clinical stage biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages to transform the treatment of cancer and other serious illness. Type: | 4 | 1 | 3 | 99 |
 | Platinum Informatics Ltd. Changing the world one experiment at a time. Platinum Informatics provides cloud-based software solutions which lay the foundations to manage big data and ensure reproducible results, whilst overcoming the challenges of remote working. With a focus on application in early-stage drug, vaccine and biomarker discovery in the growing area of precision medicine. Our vision is to build a world class Laboratory Informatics Company, that transforms scientific experimentation by bringing the digital laboratory of the future to the research laboratories of today. Type: | 0 | 0 | 0 | 1 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 37 |
 | TRICARES TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system. Type: | 0 | 0 | 0 | 22 |
 | Insight Biosolutions Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK Type: | 3 | 2 | 0 | 4 |
 | Diabeloop Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡ We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed … Type: | 33 | 16 | 15 | 125 |
 | InnaVirVax InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the … Type: | 0 | 0 | 0 | 0 |
 | PrediTox Your genotoxicity R&D partner PrediTox commits to support its clients in evaluating the genotoxic and potentially carcinogenic properties of their compounds. With more than 10 years of expertise in the study of genotoxicity, the PrediTox team will meet your expectations thanks to its innovative technique as soon as possible. Since our assay adapts to any compounds and can be carry out on any type of human cell lines, we are able to offer you personalized studies. Our goal is to provide quality information to our customers to help you in your R&D works or in your various projects, while reducing … Type: | 1 | 0 | 1 | 3 |
 | Digital Ease® [Automatic translation follows] Facilitate access to digital through scalable rental You need to finance: > your computer equipment and software, > your video systems, > your communications and telephone equipment, > your medical or laboratory equipment, > your measuring instruments, > your robots and cobots, AGV, AMR, exoskeletons, > your industrial equipment, > your handling equipment, > ... Opt for financial leasing DIGITAL EASE facilitates companies' access to technological solutions thanks to scalable rental solutions adapted to both user companies and solution providers. DIGITAL EASE supports solution providers (manufacturers, distributors, software publishers, integrators, etc.) and in particular start-ups in setting … Type: | 6 | 1 | 5 | 1 |
 | Lightinderm [Automatic translation follows] Develops innovative technological systems for skin care intended for home use. Lightinderm is a French start-up hosted at Cochin Hospital in Paris, which develops innovative technological systems for skin care intended for use at home. Inspired by dermatological treatments, its multi-patented innovation combines for the first time photobiomodulation, photo-active serum capsules and tissue massages. This unique combination activates the natural regeneration of cells and visibly improves the quality of the skin. 9 years of research - 43 patents - 7 clinical studies Medical Devices and Cosmetics Type: | 1 | 1 | 0 | 16 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 11 | 7 | 5 | 123 |
 | UseConcept [Automatic translation follows] Take care of the ergonomics of health products! Specialists in the Aptitude for the Use of Medical Devices. We help you design a product that is relevant, intuitive, safe and pleasant to use. UseConcept supports you in taking care of ergonomics in the design and improvement phases of your products and services. Specializing in user innovations, we have particular expertise in medical IT, medical devices as well as new technologies linked to commerce. We help you better understand the needs of your users and design a product that is complete, intuitive, secure and pleasant to use. These … Type: | 3 | 2 | 2 | 11 |
 | Phenocell Your partner for finely tuned in vitro R&D solutions | For the pharmaceutical and dermo-cosmetic industry Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell … Type: | 2 | 3 | 0 | 8 |
 | Unibiome (Peer To Peer Probiotics) Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification Type: | 0 | 0 | 0 | 1 |
 | Cardiawave Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis. Innovation prize winner of many contests, Cardiawave is a clinical-stage company which develops an innovative non-invasive image-guided medical device (MD) to treat aortic valve stenosis with ultrasound technology. Aortic stenosis is a life-threatening disease which is a major public health concern in Western countries (10 million people affected). The MD uses focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. The company was created at the end of 2014 as a result of a long-term partnership between the Langevin Institute / Physics for Medicine Paris, … Type: | 20 | 12 | 11 | 36 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing Tags: FrenchTech2030 Type: | 12 | 7 | 8 | 44 |
 | Arbiom Excellence in protein Arbiom is committed to feeding the world in a sustainable and healthy way. We are mastering the feedstock flexibility, to create the next generation of fermentation products and technologies. We are able to deliver high-quality and sustainable protein ingredients by tapping into nature-based solutions. Arbiom has created two protein-rich ingredients: SylPro for feed with high protein content, excellent digestibility and outstanding palatability suitable for petfood and feed nutrition; Yusto for food which bring quality, taste and well-being to nourrish people sustainably through meat and dairy analogs and specialized nutrition. Arbiom is now focusing on its industrial deployment, … Type: | 10 | 3 | 5 | 25 |
 | ANTABIO Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant Type: | 6 | 3 | 4 | 17 |
 | CITRAGE, Stratégies nutritionnelles innovantes dédiées à la santé des séniors [Automatic translation follows] CITRAGE is a research and development company in the field of health nutrition. In partnership with Paris Descartes University, it develops food supplements and oral nutritional supplements intended for people over 50 years old. The two main products are made up of 100% L-Citrulline, a non-protein amino acid, having a direct action on muscle protein synthesis, thus optimizing the use of other amino acids and allowing better muscle maintenance. - MyoCIT is a food supplement to preserve muscle capital during aging, it is intended for young seniors to prevent age-related muscle wasting (causing loss of tone, dynamism, … Type: | 0 | 0 | 0 | 7 |
 | Theranexus Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous. Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease. Type: | 9 | 5 | 4 | 17 |
 | Pharmanity [Automatic translation follows] PHARMAnity, your local pharmacies 💻 Pharmanity.com allows patients to easily access information about nearby pharmacies listed free of charge on the search engine: contact details, opening hours, products available and prices, services offered and areas of specialization. 👉 Pharmacies can register for free and reference their practical information and all their health-related activities (referencing their medications, areas of specialization and services (screenings, pharmaceutical interviews). Internet, Pharmacies, Health, and Search Engine Type: | 2 | 2 | 0 | 3 |
 | VALANX Biotech Superpowering proteins. VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis. Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, and Research and Development Tags: H2020 Type: | 2 | 0 | 2 | 10 |
 | BioNTech R&D (Austria) GmbH Subsidiary of BioNTech SE, now trading as BioNTech R&D (Austria). Developing novel anti-bacterials. BioNTech R&D Austria GmbH (formerly: PhagoMed Biopharma GmbH) is a fully owned subsidiary of BioNTech. The team in Vienna focuses on developing novel anti-bacterial drugs for persistent bacterial infections. Biotech Type: | 0 | 0 | 0 | 3 |
 | Virtus Trading LLC (A Virtus Holding Company) Making the difference... VTL has a long proven experience in introducing cutting-edge healthcare equipment and solutions from world-class manufacturers. Their diverse capabilities in Marketing, Sales, Application Support and Service of a wide and comprehensive range of medical equipment and consumables for healthcare facilities, rehabilitation and wellness, makes them a leading solution provider in the region. Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 30 professionals who have contributed to the 75 Million AED revenue in 2014. VTL offers customers advanced medical management services, medical … Type: | 1 | 0 | 1 | 42 |
 | Orio Therapeutics At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the … Type: | 0 | 0 | 0 | 1 |
 | Pelago Bioscience AB Pelago Bioscience Pelago Bioscience AB is founded to accelerate the use and value of the CETSA® technology in Drug Discovery and diagnostics. We know that the need for Target Engagement studies is large and increasing and there is no single technology with the same opportunities to fill this need as CETSA®. We will: - Make more relevant data available to our customers at an earlier stage of the Drug Discovery process - Enable filtering of compounds based on physiologically relevant data to facilitate better decisions in Drug Discovery programs - Provide our customers with CETSA® based Target Engagement data in … Type: | 1 | 0 | 1 | 52 |
 | Intervacc AB A new generation of vaccines based on fusions of recombinant proteins A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile. Veterinary, Vaccines, Animal Health, Biotech, Recombinant Vaccines, Veterinary Products, Microbiology, Wholesale, and Research and Development Type: | 0 | 0 | 0 | 12 |
 | IO Biotech Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has … Type: | 0 | 0 | 0 | 75 |
 | Merus N.V. Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of … Type: | 0 | 0 | 0 | 242 |
 | Mable Therapy Award-winning Speech Therapy and Counselling service for Schools, Colleges and Local Authorities. Mable has changed the way therapy is delivered in schools; streamlining communication between teacher, therapist and parents and delivering an evidence-based intervention that is not only functional but fun! We create memorable therapeutic experiences for pupils and all teaching staff. Speech and Language Therapy, Digital Health, Telepractice, Edtech, Education, Special Needs, Challenging Behaviour, SEMH, SEND, Speech Pathologist, Online Therapy, Children's Speech Therapy, Counselling, Psychotherapy, Wellbeing, Anxiety, Depression, Autism, Deafness, Developmental Langauge Disorder, Speech delay, and Teaching Type: | 0 | 0 | 0 | 68 |
 | Lightcast Profiling function, cell by cell Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics. Type: | 0 | 0 | 0 | 106 |
 | Bactolife Empowering worldwide health through a fortified gut microbiome We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we're pioneering the future of gut health with our unique ingredients, Binding Proteins. These breakthrough Binding Protein ingredients, natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome—a truly revolutionary approach. Our products are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by investors such … Type: | 3 | 1 | 2 | 48 |
 | Europhartech [Automatic translation follows] DOMES PHARMA MANUFACTURING Production site of the Dômes Pharma Group EUROPHARTECH is also CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specializing in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator, hospital ATU/AMM and unit EHPAD BUD, PDA, generic and nutraceutical markets. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group, historically specialized in Animal Health and present in Human Health since 1992. Laboratory approved by … Type: | 2 | 1 | 0 | 73 |
 | Fited Omurga Sağlığınız Önceliğimiz. Kişiye Özel Tasarım 3D Korseniz bir haftada hazır. Ücretsiz ön değerlendirme>05426577406 Fited makes patient-specific 3D printed braces. custom-fit, 3d Printed, medical device, medtech, and healthcare Type: | 3 | 0 | 3 | 9 |
 | Sino Biological, Inc. Sino Biological, Inc., currently listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), is an international reagent supplier and premium technical contract service, provider. Since 2007, we have committed to providing high-quality, independently developed, and produced recombinant proteins, antibodies, and cDNA clones for basic, translational, and clinical research. Sino Biological has amassed a global presence with its headquarters in Beijing, China, and subsidiaries in Suzhou and Taizhou, China, the United States, Europe, and Japan. Including two branches in Shanghai and Guangzhou, China, we have over 645,000 square ft of office space and laboratory facilities. Moreover, a new bioprocessing center … Type: | 2 | 1 | 0 | 178 |
 | Menarini Silicon Biosystems Rare cells analysis with single cell precision. Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArrayTM technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision. Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries. Read our Netiquette here: www.siliconbiosystems.com/netiquette cell sorting, … Type: | 1 | 1 | 0 | 173 |
 | Laminar Pharma Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs. Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the … Type: | 1 | 0 | 1 | 30 |
 | The American Academy of Anti-Aging Medicine (A4M) Redefining Medicine A4M is dedicated to the advancement of tools, technology, and transformations in healthcare that can detect, prevent, and treat age-related diseases. A4M further promotes the research of practices and protocols that have the potential to optimize the human aging process. The organization is also dedicated to educating healthcare professionals and practitioners, scientists, and members of the public on biomedical sciences, breaking technologies, and issues related to the anti-aging industry. Our mission is to redefine modern medicine by providing clinicians with the education and resources needed to provide whole person care that optimizes healthspan and vitality for patients worldwide. … Type: | 0 | 0 | 0 | 73 |
 | Evamed [Automatic translation follows] Experts in the clinical evaluation of medical devices Evamed is a C.R.O expert in the clinical evaluation of medical devices. We support manufacturers, learned societies and public organizations with their interventional studies, registers and observational studies. Our experience and Evamed's strong medical device culture make it a trusted player and a preferred partner for your clinical study projects. We can support you throughout your entire project (Protocol, eCRF, Management, Monitoring, Data-management, Statistics, Reports) or collaborate on specific stages. Do you want to carry out a post-marketing surveillance study, obtain your CE marking or your reimbursement? Evamed ensures … Type: | 8 | 3 | 7 | 37 |
 | Euro-Pharmat [Automatic translation follows] Expertise, skills, training, objective information for the proper use of medical devices. Objective, validated information on Sterile Medical Devices. For almost 40 years, the experience of real-time information. A training activity through annual National Days and a training catalog. French pharmaceutical scholarly society of medical devices defined by its new statutes in 2021. Information Database and Training Organization Type: | 10 | 1 | 9 | 8 |
 | Delmont Imaging Imaging all the women Delmont imaging is a company located in La Ciotat, France. Specialized in the design of medical devices for gynecology, our mission is to improve the care and management of all patients, regardless of age and future, by providing innovative, effective and less traumatic solutions. Our products are in line with the general trend of the outpatient surgery and more particularly with the «See & Treat» concepts. Gynecology, Hysteroscopy, and Medical imaging Type: | 1 | 0 | 1 | 22 |
 | Koniku Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw" biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are … Type: | 7 | 2 | 5 | 7 |
 | Vortex Biosciences Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have entered the patient bloodstream. These CTCs are known to be the key cause of secondary tumors in patients. As a result, the number and type of CTCs in a patient blood is highly indicative of the status of cancer in that patient. CTCs provide insight into the source of the primary tumor, grade, invasiveness, response to therapy and recurrence. As an indication, approximately 1.5 million new cancer patients are diagnosed per year in the United States, and around 20 million existing patients are undergoing … Type: | 1 | 1 | 1 | 10 |
 | Sesame Pay half. Be whole. Sesame is building a radically new healthcare system for uninsured Americans and those with high-deductible plans. The company's marketplace replaces historically inefficient, expensive healthcare with a direct connection – either virtually or in-person – between patients and physicians. This direct connection enables Sesame to offer doctor visits, labs, imaging and prescription drugs at half the price. Founders include a Harvard PhD in health policy and economics; a former Goldman Sachs analyst; and entertainment executive and healthcare reformer David Goldhill, author of the legendary cover story in The Atlantic, "How American Health Care Killed My Father." Sesame … Type: | 6 | 2 | 5 | 136 |
 | Multus Feeding food. 🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To … Type: | 10 | 3 | 5 | 25 |
Startup